positions at Boston Consulting Group (BCG) three years earlier, driven by a bold vision to tackle the global crisis of
antibiotic resistance using phages, viruses with the remarkable ability to target specific bacteria. Despite a robust
commitment to R&D yielding deeper insights into phage biology, the journey from lab to clinic was frustratingly
slow. And with their capital dwindling, they faced the urgent need to reassess their strategic direction and resource
allocation.
PhagoMed: The quest for phage therapy
Francis de Véricourt Cassandra Teo Ogbogu Kalu Vanshika Gupta
Product #:ESMT-824-0200-1
Supplier:ESMT European School of Management and Technology
Discipline:Finance
Setting:Europe
Subjects:
Industries:
Your Price:$9.71
Purchase this material with a free Educator Account and enjoy more benefits:
- Free Educator Copy
- Free Teaching Notes
- Build your coursepack
- Discounted academic price
Learning Objectives
2.Resource allocation strategies to managing technological risk.
3.The challenges of scientific reframing due to confirmation bias.
4.Funding strategies for a novel deep-tech idea before conducting scientific experiments.
5.The impact of advancements in digital technologies on deep-tech innovation.